The Role Of Critical Molecules In Proliferation and Apoptosis In Tumoral And Peri-Tumoral Microenvironments Of Gastric Cancer
Abstract views: 81
/ 
PDF downloads: 21
DOI:
https://doi.org/10.62482/pmj.20Keywords:
AKT, AMPK, c-MYC, gastric cancer, mTORAbstract
Introduction: Gastric cancers (GC) are one of the main causes of cancer-related deaths worldwide. Despite the dizzying progress in diagnostic and therapeutic strategies, many GC cases are diagnosed at advanced stages. Various signaling pathways have been identified to play vital roles in GC. Although the importance of these signaling pathways in GC has been demonstrated, further clinical studies are needed. Therefore, the expression of some signaling proteins in the tumoral and peri-tumoral microenvironments of GC are examined in this study.
Methods: Protein expression levels were analyzed using Western blotting method in tumor and non-tumorous tissues from nine GC sufferers. The Kaplan-Meier method was used for the log-rank test to estimate survival curves and examine the survival distribution.
Results: It was found that overexpression of c-MYC, mTOR, and AKT alongside decreased degrees of AMPK and TRAIL in GC tissues. Kaplan-Meier survival analysis highlighted worse survival outcomes in patients with high mTOR and AKT expression, while high TRAIL levels were associated with improved survival. Interestingly, a poorer prognosis was associated with higher c-MYC expression, highlighting the oncogenic role of this protein in GC through the AKT/mTOR pathway. On the other hand, decreased AMPK expression implied a lack of tumor-suppressive properties, most likely due to mTOR activation.
Conclusion: These outcomes highlight the intricate interplay between GC's tumor-suppressive and carcinogenic mechanisms. Targeting these molecules by inhibiting mTOR or activating AMPK may provide new treatment approaches which can significantly increase TRAIL sensitivity. Moreover, further studies are necessary to confirm the present results and establish the integrated therapy approaches.
References
Liu J, Feng W, Liu M, Rao H, Li X, Teng Y, Yang X, Xu J, Gao WQ, Li L. Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling. Bosn J Basic Med Sci. 2021 Aug;21(4):434. https://doi.org/10.17305/bjbms.2020.4978.
Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho WC, Rostamzadeh D. mTOR-mediated regulation of immune responses in cancer and tumor microenvironment. Front Immunol. 2022 Feb; 12:774103. https://doi.org/10.3389/fimmu.2021.774103
Wiese W, Barczuk J, Racinska O, Siwecka N, Rozpedek-Kaminska W, Slupianek A, Sierpinski R, Majsterek I. PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities. Cancers (Basel). 2023 Nov; (21):5297. https://doi.org/10.3390/cancers15215297
Sohretoglu D, Zhang C, Luo J, Huang S. ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells. Signal Transduct Target Ther. 2019 Jun; 28;4(1):21. https://doi.org/10.1038/s41392-019-0056-7
Vucicevic L, Misirkic M, Janjetovic K, Vilimanovich U, Sudar E, Isenovic E, Prica M, Harhaji-Trajkovic L, Kravic-Stevovic T, Bumbasirevic V, Trajkovic V. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway. Autophagy. 2011 Jan; 7(1):40-50. https://doi.org/10.4161/auto.7.1.13883
Sohretoglu D, Zhang C, Luo J, Huang S. ReishiMax inhibits mTORC1/2 by activating AMPK and inhibiting IGFR/PI3K/Rheb in tumor cells. Signal Transduct Target Ther. 2019 Jun; 4(1):21. https://doi.org/10.1038/s41392-019-0056-7
Tahtasakal R, Hamurcu Z, Oz AB, Balli M, Dana H, Gok M, Cinar V, Inanc M, Sener EF. miR-484 as an “OncomiR” in Breast Cancer Promotes Tumorigenesis by Suppressing Apoptosis Genes. Ann Surg Oncol. 2024 Dec; 18:1-5. https://doi.org/10.1245/s10434-024-16656-0
Tahtasakal R, Sener EF, Delibasi N, Hamurcu Z, Mehmetbeyoglu E, Bayram KK, Gunes I, Goksuluk D, Emirogullari ON. Overexpression of the PTEN Gene in Myocardial Tissues of Coronary Bypass Surgery Patients. Arq Bras Cardiol. 2023 Apr; 120:e20220169. https://doi.org/10.36660/abc.20220169
Sener EF, Hamurcu Z, Taheri S, Tahtasakal R, Delibasi N, Elcik D, Mehmetbeyoglu E, Tuncay A, Dal F, Bayram KK, Gunes I. Comparison of Cardioplegic Solutions in Coronary Bypass Surgery Over Autophagy and Apoptosis Mechanisms. Arq Bras Cardiol. 2023 Jul; 120:e20220479. https://doi.org/10.36660/abc.20220479
Das SK, Lewis BA, Levens D. MYC: a complex problem. Trends Cell Biol. 2023 Mar; 33(3):235-46. https://doi.org/10.1016/j.tcb.2022.07.006
Lin Z, Pan R, Wu L, Zhu F, Fang Q, Kwok HF, Lu X. AFP-HSP90 mediated MYC/MET activation promotes tumor progression in hepatocellular carcinoma and gastric cancers. Cancer Cell Int. 2024 Aug; 24(1):283. https://doi.org/10.1186/s12935-024-03455-6
Liu YY, Zhang YY, Ran LY, Huang B, Ren JW, Ma Q, Pan XJ, Yang FF, Liang C, Wang XL, Wang SM. A novel protein FNDC3B-267aa encoded by circ0003692 inhibits gastric cancer metastasis via promoting proteasomal degradation of c-Myc. J Transl Med. 2024 May; 22(1):507. https://doi.org/10.1186/s12967-024-05225-4
Chen SL, Zhang B, Wang S, Yang M, Shen QH, Zhang R, Xiong Z, Leng Y. Correlation between inflammatory cytokines and the likelihood of developing multiple types of digestive system cancers: A Mendelian randomization study. Cytokine. 2024 Nov; 183:156735. https://doi.org/10.1016/j.cyto.2024.156735
Li L, Niu Q, Zhu Y, Fan B, Yang G. Decitabine enhances the tumoricidal potential of TRAIL via the epigenetic regulation of death receptor 4 in gastric cancer. J Gastrointest Oncol. 2022 Dec;13(6):2799. https://doi.org/10.21037/jgo-22-928
Shah K, Parikh N, Rajendran P. The role of polyphenols in the modulation of oxidative stress-induced apoptosis in cancer cells: A review. Rev Bras Farmacogn. 2021 Nov;31(5):472-92. https://doi.org/10.1007/s43450-021-00156-8
Kaur P, Kaur A, Khurana N, Kaur R. Targeting PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma: Therapeutic implications. Curr Cancer Drug Targets. 2023 Jan;23(1):55-70. https://doi.org/10.2174/1568009622666220812122347
Wang H, Zhang Y, Wu X, Liu X, Fu B. Regulation of autophagy in gastric cancer: Advances and therapeutic implications. Cancer Cell Int. 2022 Sep; 22(1):273. https://doi.org/10.1186/s12935-022-02641-9
Kim SY, Kim HR, Kim HJ, Kim SH. The potential of dietary phytochemicals in targeting the c-Myc oncogene in cancer therapy. Nutrients. 2023 Mar; 15(3):1208. https://doi.org/10.3390/nu15031208
Luo J, Li H, Zhang J, Xu L, Wang Y. Crosstalk between the tumor microenvironment and autophagy in cancer progression and therapy. Front Oncol. 2022 Dec; 12:989632. https://doi.org/10.3389/fonc.2022.989632
Zhang T, Zhang L, Li W, Chen Y, Feng Y. The PI3K/Akt/mTOR pathway as a therapeutic target in gastric cancer: Opportunities and challenges. Biomed Pharmacother. 2023 May; 159:114256. https://doi.org/10.1016/j.biopha.2023.114256
Gao J, Li C, Xie Z, Liu R, Deng L. Role of AMPK/mTOR signaling in cancer: Therapeutic implications and drug discovery. Drug Discov Today. 2022 Jul;27(7):2042-57. https://doi.org/10.1016/j.drudis.2022.05.011
Huang S, Wu Q, Ren J, Li J, Wang Y. mTORC1/2 dual inhibitors in cancer therapy: Current status and future perspectives. J Hematol Oncol. 2023 Jun; 16(1):62. https://doi.org/10.1186/s13045-023-01452-1
Nguyen T, Tran H, Pham T, Nguyen P, Le T. Natural compounds targeting PI3K/Akt/mTOR pathway in cancer therapy: Recent advances and future directions. Molecules. 2023 Apr; 28(7):3124. https://doi.org/10.3390/molecules28073124
Smith RD, Jones TM, Taylor K, Brown P. Inhibition of mTOR signaling as a novel therapeutic approach in gastrointestinal cancers. Cancer Lett. 2022 Aug; 544:215787. https://doi.org/10.1016/j.canlet.2022.215787
Choi H, Kim J, Park E, Shin Y, Lee D. The interplay between autophagy and apoptosis in cancer: Mechanisms and therapeutic opportunities. Int J Mol Sci. 2023 Sep; 24(18):13375. https://doi.org/10.3390/ijms241813375
Zhao Y, Li X, Wang S, Sun X, Yang P. The role of inflammatory cytokines in gastric cancer progression: Implications for targeted therapy. Cytokine Growth Factor Rev. 2023 Feb;67:37-48. https://doi.org/10.1016/j.cytogfr.2023.01.004
Wu L, Deng H, Li P, Guo Q, Wang H. Emerging roles of AMPK activators in cancer treatment: Mechanisms and therapeutic implications. Biochem Pharmacol. 2022 Oct;203:115255. https://doi.org/10.1016/j.bcp.2022.115255
Liang C, Zhang Y, Zhang W, Liu Z, Chen X. Targeting c-Myc in cancer therapy: Current perspectives and challenges. Oncogene. 2023 Jan;42(1):17-33. https://doi.org/10.1038/s41388-022-02412-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Venhar Cinar, Zuhal Hamurcu, Dilara Sönmez, Onur Dülger, Islim Kaleler, Mehmet Tolgahan Hakan, Ozlem Küçükhüseyin, Sidar Bagbudar, Ceylan Hepokur, Cem Horozoğlu, Fikret Mikail Aktaş, Soykan Arıkan, İlhan Yaylım
This work is licensed under a Creative Commons Attribution 4.0 International License.
